
Moderna, a leading biotechnology company, has recently announced a groundbreaking partnership with OpenAI to ramp up the development of life-saving treatments. By deploying ChatGPT Enterprise to their vast workforce, Moderna has seen a surge in productivity and innovation within their organization.
One of the most impressive outcomes of this collaboration is the creation of customized versions of ChatGPT, including the pilot Dose ID GPT. This specialized tool utilizes advanced data analysis to evaluate and verify the optimal vaccine dose chosen by Moderna’s clinical study team.
The integration of AI technology like ChatGPT has revolu......
Read Full article on HadNews
Comments
Post a Comment